Hatteras’ mission is to build transformational human medicine companies that benefit patients and the professionals who serve them. Over half of our portfolio companies were created with our initial investment.

At Hatteras Venture Partners, we believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health.

The Hatteras team brings operational experience, a renowned strategic partner network, and a successful investment track record. We are passionate about utilizing our backgrounds to engage entrepreneurs and enhance the value of their companies.


Latest News

Elligo Health Research Raises $16M to Improve Access to Clinical Trials

March 20, 2018

March 20, 2018 — AUSTIN, TX (BUSINESS WIRE) — Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to…

More News